Published Research

Scientific research is extremely important in improving the treatment and curability of PMP, appendix cancer, and related peritoneal surface malignancies.

The utility of PAX8 and SATB2 immunohistochemical stains in distinguishing ovarian mucinous neoplasms from colonic and appendiceal mucinous neoplasm Najla Aldaoud, Madiha Erashdi, Sohaib AlKhatib, Nour Abdo, Alia Al-Mohtaseb, and Ashley Graboski-Bauer

Risk of appendiceal cancer in patients undergoing appendectomy for appendicitis in the era of increasing nonoperative management Pamela Lu MD, Justin C. McCarty DO, MPH, Adam C. Fields MD, Katherine C. Lee MD, MS, Stuart R. Lipsitz ScD, Joel E. Goldberg MD, MPH, Jennifer Irani MD, Ronald Bleday MD, Nelya Melnitchouk MD, MSc

Value of preoperative ultrasound in evaluating the peritoneal cancer index of pseudomyxoma peritonei Lei Liang, Wenhai Wang, Nan Zhou, Jun Guo, Yiyan Lu, Hongbin Xu & Shutian Zhan

Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative Gamboa AC, Zaidi MY, Lee RM, Speegle S, Switchenko JM, Lipscomb J, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers BD, Lowy AM, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Lambert L, Hendrix RJ, Abbott DE, Vande Walle K, Lafaro K, Lee B, Johnston FM, Greer J, Russell MC, Staley CA, Maithel SK

Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy Gleeson EM, Feldman R, Mapow BL, Mackovick LT, Ward KM, Morano WF, Rubin RR, Bowne WB

Different Features of Tumor-Associated NK Cells in Patients With Low-Grade or High-Grade Peritoneal Carcinomatosis Pesce S, Belgrano V, Greppi M, Carlomagno S, Squillario M, Barla A, Della Chiesa M, Di Domenico S, Mavilio D, Moretta L, Candiani S, Sivori S, De Cian F, Marcenaro E

Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in patients with peritoneal metastasized colorectal, appendiceal and small bowel cancer Gockel I, Jansen-Winkeln B, Haase L, Niebisch S, Moulla Y, Lyros O, Lordick F, Schierle K, Wittekind C, Thieme R

Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative Levinsky NC, Morris MC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Kimbrough C, Fournier K, Lee A, Dineen S, Dessureault S, Veerapong J, Baumgartner JM, Clarke C, Zaidi MY, Staley CA, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Ronnekleiv-Kelly S, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Patel SH

Pathological prognostic factors of pseudomyxoma peritonei Yan FC, Lin YL, Zhao HY, Zhou Q, Chang H, Li Y

*Slippery Nanoparticles as a Diffusion Platform for Mucin Producing Gastrointestinal Tumors Khalili M, Zhou H, Thadi A, Daniels L, Fan Z, Morano WF, Ang J, Goldstein, E, Polyak B, Mapow B, Cheng H, Bowne WB

Robotic-assisted cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) Gabriel E, Elli E, Bagaria S, Wasif N, Grotz T, Stauffer J, Kasi PM, Asbun H

Survival after complete cytoreductive surgery and HIPEC for extensive pseudomyxoma peritonei Benhaim L, Faron M, Gelli M, Sourrouille I, Honoré C, Delhorme JB, Elias D, Goere D

Survival outcomes of appendiceal mucinous neoplasms by histological type and stage: Analysis of 266 cases in a multicenter collaborative retrospective clinical study Sueda T, Murata K, Takeda T, Kagawa Y, Hasegawa J, Komori T, Noura S, Ikeda K, Tsujie M, Ohue M, Ota H, Ikenaga M, Hata T, Matsuda C, Mizushima T, Yamamoto H, Sekimoto M, Nezu R, Mori M, Doki Y

Discordant Diagnostic Terminology and Pathologic Grading of Primary Appendiceal Mucinous Neoplasms Reviewed at a High-Volume Center Choudry HA, Pai RK, Parimi A, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Bartlett DL

Outcomes Following Cytoreduction and HIPEC for Pseudomyxoma Peritonei: 10-Year Experience Narasimhan V, Wilson K, Britto M, Warrier S, Lynch AC, Michael M, Tie J, Akhurst T, Mitchell C, Ramsay R, Heriot A

Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies Cascales Campos PA, González-Gil A, Gómez-Ruiz AJ, Gil-Gómez E, Alconchel-Gago F, Navarro-Barrios A, Martínez-García J, Alonso-Romero JL, Nieto A, Barceló-Valcarcel F, Gil-Martínez J

Spectrum of computed tomography manifestations of appendiceal neoplasms: acute appendicitis and beyond Mercier F, Dagbert F, Pocard M, Goéré D, Quenet F, Wernert R, Dumont F, Brigand C, Passot G, Glehen O; RENAPE Network

Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets Park HY, Kwon MJ, Kang HS, Kim YJ, Kim NY, Kim MJ, Min KW, Choi KC, Nam ES, Cho SJ, Park HR, Min SK, Seo J, Choe JY, Lee HK

Treatment of Peritoneal Surface Malignancies with Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC): Experience in Israel Ben-Yaacov A, Nizri E, Lahat G, Berger Y, Sadot E, Lavi R, Zippel D, Sebbag G, Avital I, Hoffman A, Gutman M, Halevy A, Schneibaum S, Ben-Ari G, Benchimol D, Klausner J, Nissan A; Israeli Peritoneal Oncology Research Group

Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal Metastases Choudry HA, Bednar F, Shuai Y, Jones HL, Pai RK, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL

Impact of Cellularity on Oncologic Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Pseudomyxoma Peritonei Choudry HA, Pai RK2, Shuai Y, Ramalingam L, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Zureikat AH, Zeh HJ, Bartlett DL

Outcomes from cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal epithelial neoplasms Narasimhan V, Pham T, Warrier S, Craig Lynch A, Michael M, Tie J, Ramsay R, Heriot A

Molecular profiling of appendiceal adenocarcinoma and comparison with right-sided and left-sided colorectal cancer Tokunaga R, Xiu J, Johnston C, Goldberg RM, Philip PA, Seeber A, Naseem M, Lo JH, Arai H, Battaglin F, Puccini A, Berger MD, Soni S,Zhang W, Hwang JJ, Shields AF, Marshall JL, Baba H, Korn WM, Lenz HJ

Impact of Cellularity on Oncologic Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Pseudomyxoma Peritonei Choudry HA, Bednar F, Shuai Y, Jones HL, Pai RK, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL

Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for patients at High-Risk of Peritoneal Metastases Morris MC, Dhar VK, Stevenson MA, Winer LK, Lee TC, Wang J, Ahmad SA, Patel SH, Sussman JJ, Abbott DE

Analysis of Mutation and Loss of Heterozygosity by Whole-Exome Sequencing Yields Insights into Pseudomyxoma Peritonei Pengelly RJ, Rowaiye B, Pickard K, Moran B, Dayal S, Tapper W, Mirnezami A, Cecil T, Mohamed F, Carr N, Ennis S

Mutation Profile of High-Grade Appendiceal Mucinous Neoplasm Liao X, Vavinskaya V, Sun K, Hao Y, Li X, Valasek M, Xu R, Polydorides AD, Houldsworth J, Harpaz N

Systemic chemotherapy and survival in patients with metastatic low-grade appendiceal mucinous adenocarcinoma Lu P, Fields AC, Meyerhardt JA, Davids JS, Shabat G, Bleday R, Goldberg JE, Nash GM, Melnitchouk N

Blood-Based Next-Generation Sequencing Analysis of Appendiceal Cancers Shaib WL, Zakka K, Staley C 3rd, Roberts A, Akce M, Wu C, Alese OB, El-Rayes BF

Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy Beal EW, Ahmed A, Grotz T, Leiting J, Fournier KF, Lee AJ, Dineen S, Dessureault S, Baumgartner JM, Veerapong J, Clarke C, Strong E, Maithel SK, Zaidi MY, Patel S, Dhar V, Hendrix R, Lambert L, Johnston F, Fackche N, Raoof M, LaRocca C, Ronnekleiv-Kelly S, Pokrzywa C, Pawlik TM, Abdel-Misih S, Cloyd JM

Molecular and Genetic Markers in Appendiceal Mucinous Tumors: A Systematic Review Stein A, Strong E, Clark Gamblin T, Clarke C, Tsai S, Thomas J, George B, Mogal H

Treatment patterns and outcomes in goblet cell carcinoid tumors of the appendix Fields AC, Lu P, Enzinger A, Goldberg J, Irani J, Bleday R, Nash G, Melnitchouk N

Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin Moaven O, Votanopoulos KI, Shen P, Mansfield P, Bartlett DL, Russell G, McQuellon R, Stewart JH, Levine EA

Impact of Referral Center Pathology Review on Diagnosis and Management of Patients With Appendiceal Neoplasms Jedrzkiewicz J, Tateishi Y, Kirsch R, Conner J, Bischof D, McCart A, Riddell R, Pollett A, Taylor EL, Govindarajan A

Early recurrence in peritoneal metastasis of appendiceal neoplasm: Survival and prognostic factors Kyang LS, Alzahrani N, Alshahrani M, Rahman MK, Liauw W, Morris D

Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy Levine Teixeira Farinha H, Grass F, Labgaa I, Pache B, Demartines N, Hübner M

Pseudomyxoma Peritonei: Presentation of Two Cases and Challenging Issues in the Literature Pantiora EV, Massaras D, Koutalas J, Melemeni A, Fragulidis GP

Low-grade Appendiceal Mucinous Neoplasm Presenting as Adnexal Mass: A Case Report Pantiora EV, Massaras D, Koutalas J, Bagiasta A, Kontis EA, Fragulidis GP

Pleuropulmonary Recurrence Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Appendiceal Pseudomyxoma Peritonei Beane JD, Wilson GC, Sutton JM, Shuai Y, Ramalingam L, Jones HL, Pingpank JF, Holtzman MP, Zureikat AJ, Ahrendt SA, Zeh HJ, Bartlett DL, Choudry HA

Mucinous appendiceal neoplasms: classification, imaging, and HIPEC Bartlett DJ, Thacker PG Jr, Grotz TE, Graham RP, Fletcher JG, VanBuren WM, Iyer VR, Fidler JL, Menias CO, Wasif N, Sheedy SP

Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience Alzahrani NA, Valle SJ, Fisher OM, Sugarbaker PH, Yonemura Y, Glehen O, Goere D, Honore C, Brigand C, de Hingh I, Verwaal VJ, Deraco M, Baratti D, Kusamura S, Pocard M, Piso P, Maerz L, Marchal F, Moran B, Levine EA, Dumont F, Pezet D, Abboud K, Kozman MA, Liauw W, Morris D

Predictors of Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Paredes AZ, Abdel-Misih S, Schmidt C, Dillhoff ME, Pawlik TM, Cloyd JM

Biological mesh is a safe and effective method of abdominal wall reconstruction in cytoreductive surgery for peritoneal malignancy Tzivanakis A, Dayal SP, Arnold SJ, Mohamed F, Cecil TD, Venkatasubramaniam AK, Moran BJ

Non-home Discharge and Prolonged Length of Stay After Cytoreductive Surgery and HIPEC Burguete D, Mokdad AA, Augustine MM, Minter R, Mansour JC, Choti MA, Polanco PM

Outcomes of Low-Grade Appendiceal Mucinous Neoplasms with Remote Acellular Mucinous Peritoneal Deposits Roxburgh CS, Fenig YM, Cercek A, Shia J, Rassam RM, Paty PB, Nash GM

Short-term complications in elderly patients undergoing CRS and HIPEC: A single center’s initial experience Oemrawsingh A, de Boer NL, Brandt-Kerkhof ARM, Verhoef C, Burger JWA, Madsen EVE

Laparoscopic ileocecal resection can be applied for appendiceal cancer with an ileal fistula: A case report Mukohyama J, Sumi Y, Kanemitsu K, Hasegawa H, Yamamoto M, Kanaji S, Matsuda Y, Yamashita K, Matsuda T, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y

Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal Malignancies Choudry MHA, Shuai Y, Jones HL, Pai RK, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL

Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal Malignancies Choudry MHA, Shuai Y, Jones HL, Pai RK, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL

Approach to pseudomyxoma peritonei Rizvi SA, Syed W, Shergill R

Appendiceal Neoplasms Hatch QM, Gilbert EW

Surgical Resection with Neoadjuvant Chemotherapy for Locoregionally Recurrent Appendiceal Cancer Invading the External Iliac Vessels Takahashi J, Tsujinaka S, Kakizawa N, Takayama N, Machida E, Iseya K, Hasegawa F, Kikugawa R, Miyakura Y, Suzuki K, Rikiyama T

Outcome and factors associated with aborted cytoreduction for peritoneal carcinomatosis Guerrero W, Munene G, Dickson PV, Stiles ZE, Mays J, Davidoff AM, Glazer ES, Shibata D, Deneve JL

The Problem of Appendiceal Carcinoids Galanopoulos M, Toumpanakis C

Appendicular schwannoma presenting as vague abdominal pain Alshamrani AM, Sairafi RA, Alzahrani AM, Abdel-Raheem M

Adenocarcinoma Ex-Goblet Cell: a Retrospective Experience Das S, Shi C, Du L, Idrees K, Berlin J.BJ

Peritoneal Metastases from Appendiceal Cancer Votanopoulos KI, Shen P, Skardal A, Levine EA

Patient Selection for Cytoreductive Surgery Grotz TE, Fournier KF, Mansfield PF

Referral and treatment pathways for pseudomyxoma peritonei of appendiceal origin within a national treatment programme Fish R2, Renehan AG, Punnett G, Aziz O, Fulford P, Selvasekar C, Wilson M, Halstead R, O’Dwyer ST

Outcomes of Surgical and Chemotherapeutic Treatments of Goblet Cell Carcinoid Tumors of the Appendix Tsang ES, McConnell YJ, Schaeffer DF, Lee L, Yin Y, Zerhouni , Schaff K, Speers C, Kennecke HF

Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results ofa multicenter international study Mehta S, Schwarz L, Spiliotis J, Hsieh MC, Akaishi EH, Goere D, Sugarbaker PH, Baratti D, Quenet F, Bartlett DL, Villeneuve L, Kepenekian V; PSOGI and BIG-RENAPE Working Groups

Fistula Formation Secondary to Mucinous Appendiceal Adenocarcinoma may be Related to a Favorable Prognosis: A Case Report and Literature Review Yokode M, Ikeda E, Matsui Y, Iwamura S, Mikami S, Kobayashi H, Imai Y, Kaihara S, Yamashita Y

Predicting Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendix Adenocarcinoma Aziz O, Jaradat I, Chakrabarty B, Selvasekar CR, Fulford PE, Saunders MP, Renehan AG, Wilson MS, O’Dwyer ST

Endoscopic diagnosis of a goblet cell carcinoid tumour of the appendix Falk V, Ballantyne M, Zepeda-Gómez S, Kohansal-Vajargah A

Endoscopic diagnosis of a goblet cell carcinoid tumour of the appendix Falk V, Ballantyne M, Zepeda-Gómez S, Kohansal-Vajargah A

Early experience with cytoreduction and hyperthermic intraperitoneal chemotherapy at a newly developed center for peritoneal malignancy Guerrero WL, Munene G, Dickson PV, Darby D, Davidoff AM, Martin MG, Glazer ES, Shibata D, Deneve JL

Single-center analysis of appendiceal neoplasms Tajima T, Tajiri T, Mukai M, Sugiyama T, Hasegawa S, Yamamoto S, Sadahiro S, Shimada H, Makuuchi H

Appendiceal carcinoma associated with microsatellite instability Morales-Miranda A, Rosado ID, Núñez CC, Montero FC

Impact of Synchronous Liver Resection on the Perioperative Outcomes of Patients Undergoing CRS-HIPEC Cloyd JM, Abdel-Misih S, Hays J, Dillhoff ME, Pawlik TM, Schmidt C

The hepatic bridge Sugarbaker PH

Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy (HIPEC) by Minimally Invasive Approach, an Initial Experience Arjona-Sanchez A, Rufian-Peña S, Sanchez-Hidalgo JM, Casado-Adam A, Cosano-Alvarez A, Briceño-Delgado J

Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy (HIPEC) by Minimally Invasive Approach, an Initial Experience Arjona-Sanchez A, Rufian-Peña S, Sanchez-Hidalgo JM, Casado-Adam A, Cosano-Alvarez A, Briceño-Delgado J

Pseudomyxoma peritonei in a pediatric patient: A case report and literature review Fernandes ACO, Rocha GRMD, Oliveira AD, Guimarães MD, Carvalho SC, Chojniak

Clinicopathological Features and Management of Appendiceal Mucoceles: A Systematic Review Morano WF, Gleeson EM, Sullivan SH, Padmanaban V, Mapow BL, Shewokis PA, Esquivel J, Bowne WB

Clinicopathologic characteristics of pseudomyxoma peritonei Zhou Q, Shi F, Zhao HY, Li Y, Song QK

Pseudomyxoma peritonei: A case report and review of the literature Gómez Rivas J, Alonso-Dorrego JM, Carrión DM, Vega Robalino M, González-Peramato P

MR Imaging of Secondary Massive Ovarian Edema Caused by Ovarian Metastasis from Appendiceal Adenocarcinoma Tanaka YO, Takazawa Y, Matsuura M, Omatsu K, Takeshima N, Matsueda K

A Case of Laparoscopy Assisted Ileocecal Resection for Large Appendiceal Mucinous Adenocarcinoma Hashimoto M, Murata K, Kagawa Y, Naito A, Kawai K, Sakamoto T, Murakami K, Katsura Y, Omura A, Masuzawa T, Takeno A, Yoshimura M, Takeda Y, Kato T, Tamura S

Goblet cell carcinoid of the appendix – An interobserver variability study using two proposed classification systems Maedler C, Arnason T, Dorreen A, Sapp H, Castonguay M, Murphy J, Selegean S, Huang WY

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin Delhorme JB, Severac F, Averous G, Glehen O, Passot G, Bakrin N, Marchal F, Pocard M, Lo Dico R, Eveno C, Carrere S, Sgarbura O, Quenet F, Ferron G, Goéré D, Brigand C; French National Network of Peritoneal Surface Malignancies (RENAPE)

A Case of Appendiceal Mucinous Adenocarcinoma Detected with a Bladder Tumor Tsutsumi S, Murata A, Yamauchi Y, Okano K, Yokoyama H, Kimura A, Ishizawa Y, Umehara M, Kato M, Hashimoto N, Umehara Y, Nishikawa S, Takahashi K, Morita T

Palliative Management of Peritoneal Metastases Dreznik Lambert LA, Wiseman J

Appendiceal goblet cell carcinoids and adenocarcinomas ex-goblet cell carcinoid are genetically distinct from primary colorectal-type adenocarcinoma of the appendix Jesinghaus M, Konukiewitz B, Foersch S, Stenzinger A, Steiger K, Muckenhuber A, Groß C, Mollenhauer M, Roth W, Detlefsen S, Weichert W, Klöppel G, Pfarr N, Schlitter AM

Long-term Quality of Life After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei: A Prospective Longitudinal Study Stearns AT, Malcomson L, Punnett G, Abudeeb H, Aziz O, Selvasekar CR, Fulford PE, Wilson MS, Renehan AG, O’Dwyer ST

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified? López-López V, Cascales-Campos PA, Gil E, Arevalo J, Gonzalez A, Gil J, Muñoz-Casares FC, Melero JT, Barrios P, Morales R, Ramos I, Ortega G, Camps B,González-Bayón L, Bretcha-Boix P, Farré-Alegre J, González-Moreno S, Parrilla P

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection Grotz TE, Overman MJ, Eng C, Raghav KP, Royal RE, Mansfield PF, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KF

Cancers of the appendix. Case report and literatures review Izzo P, De Santis A, Pugliese F, Valabrega S, Izzo L

Fistula Formation Secondary to Mucinous Appendiceal Adenocarcinoma May Be Related to a Favorable Prognosis: A Case Report and Literature Review Yokode M, Ikeda E, Matsui Y, Iwamura S, Mikami S, Kobayashi H, Imai Y, Kaihara S, Yamashita Y

Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy F. Mercier F. Dagbert M. Pocard D. Goéré F. Quenet R. Wernert F. Dumont C. Brigand G. Passot O. Glehen the RENAPE Network

Expert Commentary on Appendiceal Neoplasms Konstantinos I. Votanopoulos

Prediction of Resectability in Pseudomyxoma Peritonei with a New CT Score Bouquot M, Dohan A, Gayat E, Barat M, Glehen O, Pocard M, Rousset P, Eveno C

A case report of a giant appendiceal mucocele and literature review Motsumi MJ, Motlaleselelo P, Ayane G, Sesay SO, Valdes JR

Core Body Temperature but Not Intraabdominal Pressure Predicts Postoperative Complications Following Closed-System Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Administration Goldenshluger M, Zippel D, Ben-Yaacov A, Dux J, Yalon T, Zendel A, Rayman S, Mor E, Berkenstadt H, Fogel-Grinvald H, Ventorrero M, Nissan A

Cytoreductive surgery and hyperthermic intraperitenoal chemotherapy (HIPEC) for colorectal and appendiceal carcinomas with peritoneal carcinomatosis Pallas N, Karamveri C, Kyziridis D, Hristakis C, Kyriakopoulos V, Kalakonas A, Vaikos D, Tentes AK

PCI is Not Predictive of Survival After Complete CRS/HIPEC in Peritoneal Dissemination from High-Grade Appendiceal Primaries Votanopoulos KI, Bartlett D, Moran B, Haroon CM, Russell G, Pingpank JF, Ramalingam L, Kandiah C, Chouliaras K, Shen P, Levine EA

Clinical Benefit from Trametinib in a Patient with Appendiceal Adenocarcinoma with a GNAS R201H Mutation Ang C, Stollman A, Zhu H, Sarpel U, Scarborough B, Sahni G, Millis SZ

Lymph Node Positivity in Appendiceal Adenocarcinoma: Should Size Matter? Gahagan JV, Whealon MD, Phelan MJ, Mills S, Pigazzi A, Stamos MJ, Nguyen NT, Carmichael JC

Association of Fluid Administration With Morbidity in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy Eng OS, Dumitra S, O’Leary M, Raoof M, Wakabayashi M, Dellinger TH, Han ES, Lee SJ, Paz IB, Lee B

Expert Commentary on Appendiceal Neoplasms Konstantinos I. Votanopoulos

Impact of Cellularity on Oncologic Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Pseudomyxoma Peritonei Choudry HA, Pai RK, Shuai Y, Ramalingam L, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Zureikat AH, Zeh HJ, Bartlett DL

Improved survival after retrieval of 12 or more regional lymph nodes in appendiceal cancer Fleischmann I, Warschkow R, Beutner U, Marti L, Schmied BM, Steffen T

Institutional Experience with Ostomies Created During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion Pakraftar S, Ramalingam L, Shuai Y, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Zureikat AH, Zeh HJ, Bartlett DL, Choudry HA

A proposal of Brazilian Society of Surgical Oncology for standardizing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy procedures in Brazil: pseudomyxoma peritonei, appendiceal tumors and malignant peritoneal mesothelioma Batista TP, Sarmento BJQ, Loureiro JF, Petruzziello A, Lopes A, Santos CC, Quadros CA, Akaishi EH, Cordeiro EZ, Coimbra FJF, Laporte GA, Castro LS, Batista RMSS, Aguiar S Júnior, Costa WL Júnior, Ferreira FO; Comitê de Neoplasias Peritoneais e Quimioterapia Intraperitoneal Hipertérmica da Sociedade Brasileira de Cirurgia Oncológica

Stratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastasis by histological grade Grotz TE, Royal RE, Mansfield PF, Overman MJ, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KF

Suitability of the AUC ratio as an indicator of the pharmacokinetic advantage in HIPEC Mas-Fuster MI, Ramon-Lopez A, Lacueva J, Más-Serrano P, Nalda-Molina R

Utility of Appendiceal Calcifications Detected on Computed Tomography as a Predictor for an Underlying Appendiceal Epithelial Neoplasm Sagebiel TL, Mohamed A, Matamoros A, Taggart MW, Doamekpor F, Raghav KP, Mann GN, Mansfield PF, Eng C, Royal RE, Foo WC, Ensor JE, Fournier KF, Overman MJ

Risk of Ovarian Involvement in Advanced Colorectal or Appendiceal Tumors Involving the Peritoneum Mehta AM, Bignell MB, Alves S, Dayal SP, Mohamed F, Cecil TD, Moran BJ

Ultrasound characteristics of ovarian metastases from low-grade appendiceal mucinous neoplasms Moro F, Pozzati F, Mascilini F, Magoga G, Pasciuto T, Zannoni G, Scambia G, Testa AC

Association of Fluid Administration With Morbidity in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy Eng OS, Dumitra S, O’Leary M, Raoof M, Wakabayashi M, Dellinger TH, Han ES, Lee SJ, Paz IB, Lee B

Mesenteric Lymphadenectomy in Well-Differentiated Appendiceal Neuroendocrine Tumors Raoof M, Dumitra S, O’Leary MP, Singh G, Fong Y, Lee B

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified? López-López V, Cascales-Campos PA, Gil E, Arevalo J, Gonzalez A, Gil J, Muñoz-Casares FC, Melero JT, Barrios P, Morales R, Ramos I, Ortega G, Camps B, González-Bayón L, Bretcha-Boix P, Farré-Alegre J, González-Moreno S, Parrilla P

Perioperative systemic chemotherapy for peritoneal mucinous appendiceal carcinomas treated with cytoreductive surgery & HIPEC Spiliotis J, Kopanakis N, Efstathiou E, Vassiliadou D, Argiriou O, Rogdakis A, Valavanis C

Reconstruction after ureteral resection during HIPEC surgery: Re-implantation with uretero-neocystostomy seems safer than end-to-end anastomosis Pinar U, Tremblay JF, Passot G, Dazza M, Glehen O, Tuech JJ, Pocard M; BIG-RENAPE working group

Improved survival after retrieval of 12 or more regional lymph nodes in appendiceal cancer Fleischmann I, Warschkow R, Beutner U, Marti L, Schmied BM, Steffen T

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection Grotz TE, Overman MJ, Eng C, Raghav KP, Royal RE, Mansfield PF, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KF

* Predicting appendiceal tumors among patients with appendicitis Loftus TJ1, Raymond SL, Sarosi GA Jr, Croft CA, Smith RS, Efron PA, Moore FA, Brakenridge SC, Mohr AM, Jordan JR

Appendiceal Mucinous Neoplasms: Diagnosis and Management Shaib WL, Assi R, Shamseddine A, Alese OB, Staley C 3rd, Memis B, Adsay V, Bekaii-Saab T, El-Rayes BF

Mucinous appendiceal neoplasms: Incidence, diagnosis and surgical treatment Nutu OA, Marcacuzco Quinto AA, Manrique Municio A, Justo Alonso I, Calvo Pulido J, García-Conde M, Cambra Molero F, Jiménez Romero LC

Rare malignant tumors of the appendix: surgical treatment of liver metastases case reports Fichtl J, Vodička J, Třeška V, Skalický T, Tupý R, Šmíd D

Diagnostic and therapeutic laparoscopy in assessment and management of patients with appendiceal neoplasms Tan GHC, Shamji T, Mehta A, Chandrakumaran K, Dayal S, Mohamed F, Carr NJ, Rowaiye B, Cecil T, Moran BJ

Overinterpretation is common in pathological diagnosis of appendix cancer during patient referral for oncologic care Valasek MA1, Thung I, Gollapalle E, Hodkoff AA, Kelly KJ, Baumgartner JM, Vavinskaya V, Lin GY, Tipps AP, Hosseini MV, Lowy AM

Adenocarcinoma of the appendix with extra-appendicular spread: Clinico-surgical and histologic analysis of 27 cases Morera Ocón FJ, Camps Vilata B, Muñoz Forner E, Navarro Campoy C, Gallego Plazas J, Navarro Fos S

Pseudomyxoma peritonei: natural history and treatment Mittal R, Chandramohan A, Moran B

Registries on peritoneal surface malignancies throughout the world, their use and their options Verwaal VJ, Rau B, Jamali F, Gilly FN, de Hingh I, Takala H, Syk I, Pelz J, Mulsow J, van der Speeten K, Shigeki K, Iversen LH, Mohamed F1, Glehen O, Younan R, Yarema R, Gonzalez-Moreno S, O’Dwyer S, Yonemura Y, Sugarbaker P

Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgery Uemura M, Qiao W, Fournier K, Morris J, Mansfield P, Eng C, Royal RE, Wolff RA, Raghav K, Mann GN, Overman MJ

Multiple components of PKA and TGF-β pathways are mutated in pseudomyxoma peritonei Lilli Saarinen, Pirjo Nummela, Alexandra Thiel, Rainer Lehtonen, Petrus Järvinen, Heikki Järvinen, Lauri A. Aaltonen, Anna Lepistö, Sampsa Hautaniemi, Ari Ristimäk

A Prognostic Model for Evaluation of the peritoneal carcinomatosis index with CT and MRI Dohan A, Hoeffel C, Soyer P, Jannot AS, Valette PJ, Thivolet A, Passot G, Glehen O, Rousset P

Carbonic anhydrase II: a novel biomarker for pseudomyxoma peritonei Järvinen P, Kivelä AJ, Nummela P, Lepistö A, Ristimäki A, Parkkila S

Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study Hübner M, Teixeira Farinha H, Grass F, Wolfer A, Mathevet P, Hahnloser D, Demartines N

Low-Grade Appendiceal Mucinous Neoplasm Presenting as an Adnexal Mass Panagopoulos P, Tsokaki T, Misiakos E, Domi V, Christodoulaki C, Sioutis D, Papantoniou N

Prognostic factors for survival in advanced appendiceal cancers Khan F, Vogel RI, Diep GK, Tuttle TM, Lou E

Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy Gleeson EM, Feldman R, Mapow BL, Mackovick LT, Ward KM, Morano WF, Rubin RR, Bowne WB

Surgical management of appendiceal adenocarcinoid. Case report and literature review González-Sánchez-Migallón E, Valero-Navarro G, Sola-Pérez J, García-Marín J, Verdú-Fernández MÁ, Soria-Aledo V2, Aguayo-Albasini JL

Are there intra-operative hemodynamic differences between the Coliseum and closed HIPEC techniques in the treatment of peritoneal metastasis? A retrospective cohort study Rodríguez Silva C, Moreno Ruiz FJ, Bellido Estévez I, Carrasco Campos J, Titos García A, Ruiz López M, González Poveda I, Toval Mata JA, Mera Velasco S, Santoyo Santoyo J

Low-grade appendiceal mucinous neoplasm (LAMN) – 3-year endoscopic follow-up underlines benign course of LAMN type 1 Klag T, Wehkamp J, Bösmüller H, Falch C, Johannink J, Malek NP, Kirschniak 3, Goetz M

Lymph Node Positivity in Appendiceal Adenocarcinoma: Should Size Matter? Gahagan JV, Whealon MD, Phelan MJ, Mills S, Pigazzi A, Stamos MJ, Nguyen NT, Carmichael JC

*Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery Katz SC, Point GR, Cunetta M, Thorn M, Guha P, Espat NJ, Boutros C, Hanna N, Junghans RP

Quality-of-Life Evaluation After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Dodson RM, McQuellon RP, Mogal HD, Duckworth KE, Russell GB, Votanopoulos KI, Shen P, Levine EA

Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-up Fournier K, Rafeeq S, Taggart M, Kanaby P, Ning J, Chen HC, Overman M, Raghav K, Eng C, Mansfield P, Royal R

Conditional Survival as a Patient Centered Metric for Patients with Appendiceal Adenocarcinoma Sekigami Y, Rajeev R, Johnston F, Clark Gamblin T, Turaga KK

Quality-of-Life Evaluation After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Dodson RM, McQuellon RP, Mogal HD, Duckworth KE, Russell GB, Votanopoulos KI, Shen P, Levine EA

Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-up Fournier K, Rafeeq S, Taggart M, Kanaby P, Ning J, Chen HC, Overman M, Raghav K, Eng C, Mansfield P, Royal R

Conditional Survival as a Patient Centered Metric for Patients with Appendiceal Adenocarcinoma Sekigami Y, Rajeev R, Johnston F, Clark Gamblin T, Turaga KK

Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study Harlaar NJ, Koller M, de Jongh SJ, van Leeuwen BL, Hemmer PH, Kruijff S, van Ginkel RJ, Been LB, de Jong JS3, Kats-Ugurlu G, Linssen MD, Jorritsma-Smit A, van Oosten M, Nagengast WB, Ntziachristos V, van Dam GM

Toward the molecular dissection of peritoneal pseudomyxoma Pietrantonio F, Perrone F, Mennitto A, Gleeson EM, Milione M, Tamborini E, Busico A, Settanni G, Berenato R, Caporale M, Morano F, Bossi I, Pellegrinelli A, Di Bartolomeo M, de Braud F, Baratti D, Bowne WB, Kusamura S, Deraco M

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study Pietrantonio F, Berenato R, Maggi C, Caporale M, Milione M, Perrone F, Tamborini E, Baratti D, Kusamura S, Mariani L, Niger M, Mennitto A, Gloghini A, Bossi I, Settanni G, Busico A, Bagnoli PF, Di Bartolomeo M, Deraco M, de Braud F

Personalized oncogenomics in the management of gastrointestinal carcinomas-early experiences from a pilot study Sheffield BS, Tessier-Cloutier B, Li-Chang H, Shen Y, Pleasance E, Kasaian K, Li Y, Jones SJ, Lim HJ, Renouf DJ, Huntsman DG, Yip S, Laskin J, Marra M, Schaeffer DF

Intraperitoneal immunotherapy: historical perspectives and modern therapy Morano WF, Aggarwal A, Love P, Richard SD, Esquivel J, Bowne WB

Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms Polanco PM, Ding Y, Knox JM, Ramalingam L, Jones H, Hogg ME, Zureikat AH, Holtzman MP, Pingpank J, Ahrendt S, Zeh HJ, Bartlett DL, Choudry HA

PTU-105 Cytoreductive Surgery and Small Bowel Transplantation is A Feasible Option for Patients with End-Stage Pseudomyxoma Peritonei P Allan, S Reddy, B Moran, G Vrakas, H Giele, F Mohamad, J Gilbert, S Sinha, A Vaidya, T Cecil, P Friend

Ultimate Clinical Outcomes of Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential Shin R, Chai YJ, Park JW, Chang MS, Bae JM, Kim MJ, Park BK, Park KJ, Jeong SY

Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell Carcinoids Radomski M, Pai RK, Shuai Y, Ramalingam L, Jones H, Holtzman MP, Ahrendt SA, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA

Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study Baratti D, Kusamura S, Milione M, Pietrantonio F, Caporale M, Guaglio M, Deraco M

Incidentally discovered low-grade appendiceal mucinous neoplasm: a precursor to pseudomyxoma peritonei Padmanaban V, Morano WF, Gleeson E, Aggarwal A, Mapow BL, Stein DE, Bowne WB

The Management and Prognostic Prediction of Adenocarcinoma of Appendix Xie X, Zhou Z, Song Y, Li W, Diao D, Dang C, Zhang H

Lymph Node Metastasis Predicts Disease Recurrence in a Single-Center Experience of 70 Stages 1-3 Appendix Cancers: A Retrospective Review Nash GM, Smith JD, Tang L, Weiser MR, Temple LK, O’Reilly E, Saltz LB, Guillem JG, Paty PB

A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix Dineen SP, Royal RE, Hughes MS, Sagebiel T, Bhosale P, Overman M, Matamoros A, Mansfield PF, Fournier KF

Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study Baratti D, Kusamura S, Milione M, Pietrantonio F, Caporale M, Guaglio M, Deraco M

5-Aminolevulinic Acid Fluorescence in Detection of Peritoneal Metastases Yonemura Y, Canbay E, Ishibashi H, Nishino E, Endou Y, Sako S, Ogura S

Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms Choe JH1, Overman MJ, Fournier KF, Royal RE, Ohinata A, Rafeeq S, Beaty K, Phillips JK, Wolff RA, Mansfield PF, Eng C

Cytoreduction and hyperthermic intraperitoneal chemotherapy: The learning curve reassessed Kuijpers AM, Hauptmann M, Aalbers AG, Nienhuijs SW, de Hingh IH, Wiezer MJ, van Ramshorst B, van Ginkel RJ, Havenga K, Verwaal VJ

Strategies for Preventing Pseudomyxoma Peritonei After Resection of a Mucinous Neoplasm of the Appendix Honoré C, Caruso F, Dartigues P, Benhaim L, Chirica M, Goéré D, Elias D

Prophylactic hyperthermic intraperitoneal chemotherapy in patients with epithelial appendiceal neoplasms Tuvin D, Berger Y, Aycart SN, Shtilbans T, Hiotis S, Labow DM, Sarpel U

Diagnosis and Treatment of Mucinous Appendiceal Neoplasm Presented as Acute Appendicitis Kehagias I, Zygomalas A, Markopoulos G, Papandreou T, Kraniotis P

The Initial Indian Experience with Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases Bhatt A, Mehta S, Seshadri RA, Sethna K, Zaveri S, Rajan F, Mahajan V, Singh S, Raj EH, Sugarbaker PH

Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors Charrier T, Passot G, Peron J, Maurice C, Gocevska S, Quénet F, Eveno C, Pocard M, Goere D, Elias D, Ortega-Deballon P, Vaudoyer D, Cotte E, Glehen O

FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei Julien D, Francesco G, Pascal R, Naoual B, Guillaume P, Sylvie I, Olivier G, Andrea S

Effect of a concomitant urologic procedure on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy Lyon TD, Turner Ii RM, Nikonow TN, Wang L, Uy J, Ramalingam L, Holtzman MP, Pingpank JF, Bartlett DL, Davies BJ

Laparoscopic HIPEC: A bridge between open and closed-techniques Lotti M, Capponi MG, Piazzalunga D, Poiasina E, Pisano M, Manfredi R, Ansaloni L

Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility Chia CS,You B, Decullier E, Vaudoyer D,Lorimier G, Abboud K, Bereder JM, Arvieux C, Boschetti G,Glehen O,BIG RENAPE Group

Management of Appendix Cancer Kaitlyn J. Kelly, MD

Comparison of long-term oncological outcomes of appendiceal cancer and colon cancer: A multicenter retrospective study Son IT, Ahn S, Park KJ, Oh JH, Jeong SY, Park HC, Heo SC, Youk EG, Park JT, Ihn MH, Oh HK, Kim DW, Lee KH, Kang SB; Seoul Colorectal Group (SECOG)

* Prognostic Molecular Subtypes of Low-Grade Cancer of the Appendix Levine EA, Votanopoulos KI, Qasem SA, Philip J, Cummins KA, Chou JW, Ruiz J, D’Agostino R, Shen P, Miller LD

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus Liu Y, Ishibashi H, Hirano M, Takeshita K, Mizumoto A, Ichinose M, Nishino E, Kashu I, Yamamoto Y, Sugarbaker PH, Yonemura Y

Appendicular Mucocele: Possibilities and Limits of Laparoscopy. Brief Series and Review of the Literature Tărcoveanu E, Vasilescu A, Hee RV, Moldovanu R, Ursulescu C, Ciobanu D, Bradea C

Recommendations in the management of epithelial appendiceal neoplasms and peritoneal dissemination from mucinous tumours (pseudomyxoma peritonei) Barrios P, Losa F, Gonzalez-Moreno S, Rojo A, Gómez-Portilla A, Bretcha-Boix P, Ramos I, Torres-Melero J, Salazar R, Benavides M, Massuti T, Aranda E

Letter to the Editor With Regard to the Article Entitled: “A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritoneii and Associated Appendiceal Neoplasia Singhal, Shikha MBBS, MD; Giner-Segura, Francisco MD, PhD; Hompes, Roel MD; Guy, Richard MB, ChB, MD, FRCS; Wang, Lai Mun MB, BCh, MRCP, FRCPath

Hyperthermic Intraperitoneal Chemotherapy Following Cytoreductive Surgery Improves Outcome in Patients With Primary Appendiceal Mucinous Adenocarcinoma: A Pooled Analysis From Three Tertiary Care Centers Shaib WL, Martin LK, Choi M, Chen Z, Krishna K, Kim S, Brutcher E, Staley C 3rd, Maithel SK, Philip P, Abdel-Misih S, Bekaii-Saab TS, El-Rayes BF

Goblet cell appendiceal tumors–management dilemmas and long-term outcomes Rossi RE, Luong TV, Caplin ME, Thirlwell C, Meyer T, Garcia-Hernandez J, Baneke A, Conte D, Toumpanakis C

A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion Downs-Canner S, Ding Y, Magge DR, Jones H, Ramalingam L, Zureikat A, Holtzman M, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA

* Mitogen-activated protein kinase inhibition reduces mucin 2 production and mucinous tumor growth Dilly AK, Song X, Zeh HJ, Guo ZS, Lee YJ, Bartlett DL, Choudry HA

* Global gene expression in pseudomyxoma peritonei, with parallel development of two immortalized cell lines Darren L. Roberts, Sarah T. O’Dwyer, Peter L. Stern, Andrew G. Renehan

The Rise in Appendiceal Cancer Incidence: 2000-2009 Marmor S, Portschy PR, Tuttle TM, Virnig BA

Goblet cell carcinoids: characteristics of a Danish cohort of 83 patients Olsen I, Holt N, Langer SW, Hasselby JP, Grønbæk H, Hillingsø J, Mahmoud M, Ladekarl M, Iversen LH, Kjær A, Federspiel BH, Knigge U

A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix Dineen SP, Royal RE, Hughes MS, Sagebiel T, Bhosale P, Overman M, Matamoros A, Mansfield PF, Fournier KF

Institutional Learning Curve of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Malignancies Polanco PM, Ding Y, Knox JM, Ramalingam L, Jones H, Hogg ME, Zureikat AH, Holtzman MP, Pingpank J, Ahrendt S, Zeh HJ, Bartlett DL, Choudry HA

Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei Kusamura S, Moran BJ, Sugarbaker PH, Levine EA, Elias D, Baratti D, Morris DL, Sardi A, Glehen O, Deraco M; Peritoneal Surface Oncology Group International (PSOGI)

The RENAPE network: towards a new healthcare organization for the treatment of rare tumors of the peritoneum. Description of the network and role of the pathologists Villeneuve L, Isaac S, Glehen O, Capovilla M, Chevallier A, Croce S, Dartigues P, Fontaine J, Kaci R, Lang-Averous G, Laverriere MH, Leroux-Broussier A, Mery E, Poizat F, Valmary-Degano S, Verriele-Beurrier V, Gilly FN, Bibeau F

* Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin Alakus H, Babicky ML, Ghosh P, Yost S, Jepsen K, Dai Y, Arias A, Samuels ML, Mose ES, Schwab RB, Peterson MR, Lowy AM, Frazer KA, Harismendy O

* Frequent lack of GNAS mutations in colorectal adenocarcinoma associated with GNAS-mutated villous adenoma Sekine S, Ogawa R, Oshiro T, Kanemitsu Y, Taniguchi H, Kushima R, Kanai Y

* FOLFOX-4 Chemotherapy for Patients With Unresectable or Relapsed Peritoneal Pseudomyxoma Pietrantonio F, Maggi C, Fanetti G, Iacovelli R, Di Bartolomeo M, Ricchini F, Deraco M, Perrone F, Baratti D, Kusamura S, Tamborini E, Castano A, Consonni PV, Bossi I, Gavazzi C, Milione M, Pelosi G, de Braud F

GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival Singhi AD, Davison JM, Choudry HA, Pingpank JF, Ahrendt SA, Holtzman MP, Zureikat AH, Zeh HJ, Ramalingam L, Mantha G, Nikiforova M, Bartlett DL, Pai RK

Molecular Profiling of Appendiceal Epithelial Tumors Using Massively Parallel Sequencing to Identify Somatic Mutations Liu X, Mody K, de Abreu FB, Pipas JM, Peterson JD, Gallagher TL, Suriawinata AA, Ripple GH, Hourdequin KC, Smith KD, Barth RJ Jr, Colacchio TA, Tsapakos MJ, Zaki BI, Gardner TB, Gordon SR, Amos CI, Wells WA, Tsongalis GJ

Pseudomyxoma peritonei: inflammatory responses in the peritoneal microenvironment Lohani K, Shetty S, Sharma P, Govindarajan V, Thomas P, Loggie B

Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Blackham AU, Swett K, Eng C, Sirintrapun J, Bergman S, Geisinger KR, Votanopoulos K, Stewart JH, Shen P, Levine EA

Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites Randle RW, Swett KR, Swords DS, Shen P, Stewart JH, Levine EA, Votanopoulos KI

Pseudomyxoma peritonei: inflammatory responses in the peritoneal microenvironment Dohan A, Lousquy R, Eveno C, Goere D, Broqueres-You D, Kaci R, Lehmann-Che J, Launay JM, Soyer P, Bonnin P, Pocard M

Signifigance of signet ring cells in high-grade mucinous adenocarcinoma of the peritoneum from appendiceal origin Sirintrapun SJ, Blackham AU, Russell G, Votanopoulos K, Stewart JH, Shen P, Levine EA, Geisinger KR, Bergman S

Molecular Profiling of Appendiceal Epithelial Tumors Using Massively Parallel Sequencing to Identify Somatic Mutations Liu X, Mody K, de Abreu FB, Pipas JM, Peterson JD, Gallagher TL, Suriawinata AA, Ripple GH, Hourdequin KC, Smith KD, Barth RJ Jr, Colacchio TA, Tsapakos MJ, Zaki BI, Gardner TB, Gordon SR, Amos CI, Wells WA, Tsongalis GJ

Peritoneal pseudomyxoma: An overview emphasizing pathological assessment and therapeutic strategies Dartigues P, Isaac S, Villeneuve L, Glehen O, Capovilla M, Chevallier A, Croce S, Kaci R, Lang-Averous G, Laverriere MH, Leroux-Broussier A, Mery E, Poizat F, Valmary-Degano S, Verriele-Beurrier V, Gilly FN, Bibeau F

The RENAPE network: Towards a new healthcare organization for the treatment of rare tumors of the peritoneum. Description of the network and role of the pathologists Villeneuve L, Isaac S, Glehen O, Capovilla M, Chevallier A, Croce S, Dartigues P, Fontaine J, Kaci R, Lang-Averous G, Laverriere MH, Leroux-Broussier A, Mery E, Poizat F, Valmary-Degano S, Verriele-Beurrier V, Gilly FN, Bibeau F

Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases Elias D, Goéré D, Dumont F, Honoré C, Dartigues P, Stoclin A, Malka D, Boige V, Ducreux M

Whole abdominopelvic radiotherapy in the palliative treatment of pseudomyxoma peritonei Berkovic P, van de Voorde L, De Meerleer G, Delrue L, Speleers B, Van Belle S, Vandecasteele K

Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients Levine EA, Stewart JH 4th, Shen P, Russell GB, Loggie BL, Votanopoulos KI

Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survival Shetty S, Natarajan B, Thomas P, Govindarajan V, Sharma P, Loggie B

*Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms Nishikawa G, Sekine S, Ogawa R, Matsubara A, Mori T, Taniguchi H, Kushima R, Hiraoka N, Tsuta K, Tsuda H, Kanai Y

A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei Gilbreath JJ, Semino-Mora C, Friedline CJ, Liu H, Bodi KL, McAvoy TJ, Francis J, Nieroda C, Sardi A, Dubois A, Lazinski DW, Camilli A, Testerman TL, Merrell DS

Antibiotic Treatment Decreases Microbial Burden Associated with Pseudomyxoma Peritonei and Affects β-catenin Distribution Semino-Mora C, Testerman TL, Liu H, Whitmire JM, Studeman K, Jia Y, McAvoy TJ, Francis J, Nieroda C, Sardi A, Merrell DS, Dubois A

The incidence of mucinous appendiceal malignancies: a population-based study van den Heuvel MG, Lemmens VE, Verhoeven RH, de Hingh IH

Extensive Cytoreductive Surgery for Appendiceal Carcinomatosis: Morbidity, Mortality, and Survival Wagner PL, Austin F, Maduekwe U, Mavanur A, Ramalingam L, Jones HL, Holtzman MP, Ahrendt SA, Zureikat AH, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA

Mucin as a therapeutic target in pseudomyxoma peritonei Choudry HA, O’Malley ME, Guo ZS, Zeh HJ, Bartlett DL

* Life after death: targeting high mobility group box 1 in emergent cancer therapies Z Sheng Guo, Zuqiang Liu, David L Bartlett, Daolin Tang, and Michael T Lotze

Mucinous neoplasms of the appendix: a current comprehensive clinicopathologic and imaging review Sree Harsha Tirumani, Margaret Fraser-Hill, Rebecca Auer, Wael Shabana, Cynthia Walsh, Frank Lee, and John G. Ryan

Significance of Serum Tumor Marker Levels in Peritoneal Carcinomatosis of Appendiceal Origin Wagner PL, Austin F, Sathaiah M, Magge D, Maduekwe U, Ramalingam L, Jones HL, Holtzman MP, Ahrendt SA, Zureikat AH, Pingpank JF, Zeh HJ 3rd, Bartlett DL, Choudry HA

Delay of cytoreductive surgery and heated intraperitoneal chemotherapy in patients with appendiceal neoplasm El Halabi H, Macdonald R, Studeman K, Francis J, Nieroda C, Gushchin V, Sardi A

Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases Carr NJ, Finch J, Ilesley IC, Chandrakumaran K, Mohamed F, Mirnezami A, Cecil T, Moran B

Classification of and cytoreductive surgery for low-grade appendiceal mucinous neoplasms McDonald JR, O’Dwyer ST, Rout S, Chakrabarty B, Sikand K, Fulford PE, Wilson MS, Renehan AG

Experience after 100 patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Königsrainer I, Zieker D, Glatzle J, Lauk O, Klimek J, Symons S, Brücher B, Beckert S, Königsrainer A

Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI Klumpp BD, Schwenzer N, Aschoff P, Miller S, Kramer U, Claussen CD, Bruecher B, Koenigsrainer A, Pfannenberg C

CT imaging interval after complete cytoreductive surgery/hyperthermic intraperitoneal chemotherapy (HIPEC) for well-differentiated adenocarcinoma of the appendix (WDAA) Karen A. Beaty, Joshua S. Hill, Safia Rafeeq, Michael J. Overman, Tara L. Sagebiel, Aurelio Matamoros, Richard E. Royal, Paul F. Mansfield, Keith F. Fournier; University of Texas M. D. Anderson Cancer Center, Houston, TX

Early and long-term outcome data on 2,298 patients with pseudomyxoma peritonei of appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Terence C. Chua, Brendan J. Moran, Paul H. Sugarbaker, Edward Allen Levine, Olivier Glehen, Francois N. Gilly, Dominique Elias, Dario Baratti, Marcello Deraco, Armando Sardi, David L. Morris, Peritoneal Surface Oncology Group International; University of New South Wales, Sydney, Australia; NCG Pseudomyxoma Peritonei Centre, The North Hampshire Hospital, Basingstoke, United Kingdom; Washington Hospital Center, Washington, DC; Wake Forest School of Medicine, Winston-Salem, NC; Centre Hospitalo-Universitaire Lyon Sud, Lyon, France; Institut Gustave Roussy, Villejuif, France; Istituto Nazionale per la Cura e lo Studio dei Tumori , Milan, Italy; Mercy Medical Center, Baltimore, MD

Impact of tumor aneuploidy in pseudomyxoma peritonei Shreya Jagadish Shetty, Bala Natarajan, Brian W. Loggie; Creighton University Medical Center, Omaha, NE

Histopathological Classification of Pseudomyxoma Peritonei and the Prognostic Importance of PINCH Protein Andréasson H, Wanders A, Sun XF, Willén R, Graf W, Nygren P, Glimelius B, Zhang ZY, Mahteme H

The Influence of Tumor Cell Entrapment Phenomenon on the Natural History of Pseudomyxoma peritonei Syndrome Spiliotis J, Efstathiou E, Halkia E, Vaxevanidou A, Datsis A, Sugarbaker P

Right hemicolectomy is not routinely indicated in pseudomyxoma peritonei Foster JM, Gupta PK, Carreau JH, Grotz TE, Blas JV, Gatalica Z, Nath S, Loggie BW

Peritoneal Carcinomatosis: Cytoreductive Surgery and HIPEC–Overview and Basics Brücher BL, Piso P, Verwaal V, Esquivel J, Derraco M, Yonemura Y, Gonzalez-Moreno S, Pelz J, Königsrainer A, Ströhlein M, Levine EA, Morris D, Bartlett D, Glehen O, Garofalo A, Nissan A

Immunohistochemical and biochemical characterization of mucin in pseudomyxoma peritonei: a case study Mall AS, Lotz Z, Tyler M, Goldberg P, Rodrigues J, Kahn D, Chirwa N, Govender D

Pharmacokinetic study of perioperative intravenous Ifosfamide Van der Speeten K, Stuart OA, Mahteme H, Sugarbaker PH

Peritoneal carcinomatosis: imaging with 64-MDCT and 3T MRI with diffusion-weighted imaging Iafrate F, Ciolina M, Sammartino P, Baldassari P, Rengo M, Lucchesi P, Sibio S, Accarpio F, Di Giorgio A, Laghi A

Cancers of the Appendix: Review of the Literatures Carl Ruoff, Louay Hanna, Wanqing Zhi, Ghulamullah Shahzad, Vladimir Gotlieb, and Muhammad Wasif Saif

Cytoreductive surgery with intraperitoneal chemotherapy to treat pseudomyxoma peritonei at nonspecialized hospitals Kitai T, Kawashima M, Yamanaka K, Ichijima K, Fujii H, Mashima S, Shimahara Y

Cytoreductive surgery and HIPEC in peritoneal recurrent ovarian cancer: experience and lessons learned Königsrainer I, Beckert S, Becker S, Zieker D, Fehm T, Grischke EM, Lauk O, Glatzle J, Brücher B, Wallwiener D, Königsrainer A

Management of peritoneal carcinomatosis from colorectal cancer Ihemelandu CU, Shen P, Stewart JH, Votanopoulos K, Levine EA

Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix Lieu CH, Lambert LA, Wolff RA, Eng C, Zhang N, Wen S, Rafeeq S, Taggart M, Fournier K, Royal R, Mansfield P, Overman MJ

Lymph node metastasis predicts survival in patients with highgrade appendix cancer H.M. El Halabi, V. Gushchin, R. Macdonald, J. Francis, N. Athas, A. Sardi

Reappraisal of the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of ovarian cancer: a single institutional experience Melis A, Abboud K, Bourmaud A, Pacaut C, Bageacu S, Jacquin JP, Porcheron J, Merrouche Y, Magné N

Bologna Guidelines for Diagnosis and Management of Adhesive Small Bowel Obstruction (ASBO): 2010 Evidence-Based Guidelines of the World Society of Emergency Surgery Catena F, Di Saverio S, Kelly MD, Biffl WL, Ansaloni L, Mandalà V, Velmahos GC, Sartelli M, Tugnoli G, Lupo M, Mandalà S, Pinna AD, Sugarbaker PH, Van Goor H, Moore EE, Jeekel J

Primary appendiceal mucinous adenocarcinoma in two first-degree relatives: case report and review Racek AR Msii, Rabe KG M S, Wick MJ M D Ph D, Psychogios A M D, Lindor NM M D

Pseudomyxoma peritonei treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: results from a single centre Arjona-Sánchez A, Muñoz-Casares FC, Rufián-Peña S, Díaz-Nieto R, Casado-Adam A, Rubio-Pérez MJ, Ortega-Salas R

Closed Abdomen Hyperthermic Intraperitoneal Chemotherapy with Irinotecan and Mitomycin C: a Phase I Study Cotte E, Passot G, Tod M, Bakrin N, Gilly FN, Steghens A, Mohamed F, Glehen O

Netrin-4 Delays Colorectal Cancer Carcinomatosis by Inhibiting Tumor Angiogenesis Eveno C, Broqueres-You D, Feron JG, Rampanou A, Tijeras-Raballand A, Ropert S, Leconte L, Levy BI, Pocard M

Childbearing After Hyperthermic Intraperitoneal Chemotherapy: Results From an International Survey Ortega-Deballon P, Glehen O, Levine E, Piso P, Sugarbaker PH, Hayes-Jordan A, Facy A, Bakrin N, Rat P

Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study Esquivel J, Chua TC, Stojadinovic A, Melero JT, Levine EA, Gutman M, Howard R, Piso P, Nissan A, Gomez-Portilla A, Gonzalez-Bayon L, Gonzalez-Moreno S, Shen P, Stewart JH, Sugarbaker PH, Barone RM, Hoefer R, Morris DL, Sardi A, Sticca RP

Pharmacology of perioperative 5-fluorouracil Van der Speeten K, Stuart OA, Mahteme H, Sugarbaker PH

Use of FDG-PET imaging for patients with disseminated cancer of the appendix Rohani P, Scotti SD, Shen P, Stewart JH, Russell GB, Cromer M, Levine EA

Indication of Peritonectomy for Peritoneal Dissemination Yonemura Y, Tsukiyama G, Miyata R, Sako S, Endou Y, Hirano M, Mizumoto A, Matsuda T, Takao N, Ichinose M, Miura M, Hagiwara A, Li Y

Selection of patients and staging of peritoneal surface malignancies Eddy Cotte, Guillaume Passot, François-Noël Gilly, and Olivier Glehen

New approach to peritoneal surface malignancies Antonio Macrì, Department of Human Pathology, General Surgery Unit, University of Messina, 98125 Messina, Italy

Clinical presentation of pseudomyxoma peritonei Järvinen P, Lepistö A. Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland

Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O Cavaliere F, De Simone M, Virzì S, Deraco M, Rossi CR, Garofalo A, Di Filippo F, Giannarelli D, Vaira M, Valle M, Pilati P, Perri P, La Pinta M, Monsellato I, Guadagni F. Department of Surgery, San Giovanni Hospital, Via dell’Amba Aradam 9, 00184 Rome, Italy

Pseudomyxoma peritonei Katharine E Bevan, Faheez Mohamed and Brendan J Moran

A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy Tristan D Yan, Christopher Qian Cao and Stine Munkholm-Larsen

Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy Elias D, Gilly F, Quenet F, Bereder JM, Sidéris L, Mansvelt B, Lorimier G, Glehen O; Association Française de Chirurgie

A clinicopathologic analysis of peritoneal metastases of colorectal and appendiceal origin Bruin SC, Verwaal VJ, Vincent A, van’t Veer LJ, van Velthuysen ML

Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1290 patients Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, Mansvelt B, Lorimier G, Msika S, Elias D; the French Surgical Association

Complete cytoreduction offers longterm survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology Omohwo C, Nieroda CA, Studeman KD, Thieme H, Kostuik P, Ross AS, Holter DR, Gushchin V, Merriman B, Sardi A

Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience Shapiro JF, Chase JL, Wolff RA, Lambert LA, Mansfield PF, Overman MJ, Ohinata A, Liu J, Wang X, Eng C

Incidence, Risk Factors, and Impact of Severe Neutropenia After Hyperthermic Intraperitoneal Mitomycin C Lambert, Laura A.; Armstrong, Terri S.; Lee, J. Jack; Liu, Suyu; Katz, Matthew H.; Eng, Cathy;et. al

Pseudomyxoma Peritonei: A Need to Establish Evidence-Based Standard of Care—Is This the Right Trial? Terence C. Chua, BScMed (Hons), Khaled Al-Mohaimeed, MBBS, FRCS, Winston Liauw, MBBS, FRACP, and David L. Morris, MD, PhD

Appendiceal neoplasms and pseudomyxoma peritonei: a population based study Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA

Peritoneal Pseudomyxoma: Results of a Systematic Policy of Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Elias D, Honoré C, Ciuchendéa R, Billard V, Raynard B, Lo Dico R, Dromain C, Duvillard P, Goéré D

A Phase II Study Evaluating the Use of Concurrent Mitomycin C and Capecitabine (Xeloda) in Patients with Advanced Unresectable Pseudomyxoma Peritonei Farquharson AL, Pranesh N, Witham G, Swindell R, Taylor MB, Renehan AG, Rout S, Wilson MS, O’Dwyer ST, Saunders MP

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement Esquivel J, Sticca R, Sugarbaker P, Levine E, Yan TD, Alexander R, Baratti D, Bartlett D, Barone R, Barrios P, Bieligk S, Bretcha-Boix P, Chang CK, Chu F, Chu Q, Daniel S, de Bree E, Deraco M, Dominguez-Parra L, Elias D, Flynn R, Foster J, Garofalo A, Gilly FN, Glehen O, Gomez-Portilla A, Gonzalez-Bayon L, Gonzalez-Moreno S, Goodman M, Gushchin V, Hanna N, Hartmann J, Harrison L, Hoefer R, Kane J, Kecmanovic D, Kelley S, Kuhn J, Lamont J, Lange J, Li B, Loggie B, Mahteme H, Mann G, Martin R, Misih RA, Moran B, Morris D, Onate-Ocana L, Petrelli N, Philippe G, Pingpank J, Pitroff A, Piso P, Quinones M, Riley L, Rutstein L, Saha S, Alrawi S, Sardi A, Schneebaum S, Shen P, Shibata D, Spellman J, Stojadinovic A, Stewart J, Torres-Melero J, Tuttle T, Verwaal V, Villar J, Wilkinson N, Younan R, Zeh H, Zoetmulder F, Sebbag G; Society of Surgical Oncology Annual Meeting

Survival Analysis of Pseudomyxoma Peritonei Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Robert M. Smeenk, MD, Vic J. Verwaal, MD, PhD, Ninja Antonini, MSc, and Frans A. N. Zoetmulder, MD, PhD

Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy Tristan D Yan, Oswald A Stuart, Dal Yoo and Paul H Sugarbaker

Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy Stewart JH 4th, Shen P, Russell GB, Bradley RF, Hundley JC, Loggie BL, Geisinger KR, Levine EA

A Specific Cadherin Phenotype May Characterize the Disseminating Yet Non-Metastatic Behavior of Pseudomyxoma Peritonei Bibi R, Pranesh N, Saunders MP, Wilson MS, O’dwyer ST, Stern PL, Renehan AG

Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei Güner Z, Schmidt U, Dahlke MH, Schlitt HJ, Klempnauer J, Piso P

Cytoreductive surgery
with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a
prospective study
Loungnarath R, Causeret S, Bossard N, Faheez M, Sayag-Beaujard AC, Brigand C, Gilly F, Glehen O

Cytoreductive surgery
combined with perioperative intraperitoneal chemotherapy for the management of peritoneal
carcinomatosis from colorectal cancer: a multi-institutional study
Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, Barone R, Yonemura Y, Cavaliere F, Quenet F, Gutman M, Tentes AA, Lorimier G, Bernard JL, Bereder JM, Porcheron J, Gomez-Portilla A, Shen P, Deraco M, Rat P

Scientific research is extremely important in improving the treatment and curability of PMP, appendix cancer, and related peritoneal surface malignancies. Following are some of the pertinent research studies that have been published from 2004 to present.

* Research marked with an asterisk was partially or wholly funded by a PMPRF Research Grant